Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
IPSC
#3009
Century Therapeutics, Inc. Common Stock
2.3
2
+6.42%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
+6.42%
Monatliche Änderung
-13.43%
6 month change
+346.15%
Jahresänderung
+256.92%
Vorheriger Schlusskurs
2.1
8
Open
2.3
2
Bid
Ask
Low
2.3
2
High
2.3
2
Volumen
15
Märkte
Aktien
Gesundheitswesen
IPSC
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
2021
2022
2023
2024
TTM
Cash from operating activities
89 M
14.05 M
88.35 M
110.14 M
112.02 M
Cash from investing activities
298.34 M
13.13 M
61.13 M
47.48 M
115.75 M
Cash from financing activities
417.77 M
27.16 M
9.72 M
74.56 M
-482 K
Free cash flow
44.03 M
-16.55 M
74.61 M
109.98 M
111.03 M
Nachrichten
TD Cowen initiates Century Therapeutics stock rating at Buy
Oracle, Palantir among market cap stock movers on Monday
Century Therapeutics (IPSC) Upgraded to Strong Buy: Here's What You Should Know
Century Therapeutics stock price target raised to $4 from $2 at Piper Sandler
Century Therapeutics stock price target lowered to $6.60 at Clear Street
Century Therapeutics secures $135 million in private placement
FDA Grants Breakthrough Therapy Designation to ALKS' Narcolepsy Drug
Fast-paced Momentum Stock Century Therapeutics (IPSC) Is Still Trading at a Bargain
Why Fast-paced Mover Century Therapeutics (IPSC) Is a Great Choice for Value Investors
Century Therapeutics appoints two new board members
Century Therapeutics stock downgraded by Leerink Partners on lack of catalysts
Century Therapeutics unveils T1D therapy program with immune evasion tech